- Teacher who survived Sandy Hook has book deal
- Jury awards Ventura $1.8M in defamation case
- Government OKs Arab-owned company to operate U.S. cargo port
- Defense lawyer: McDonnell’s wife had ‘crush’ on CEO
- Chinese hackers stole ‘huge quantities’ of sensitive data on Israel’s Iron Dome
- House unveils bill to speed deportations of illegal immigrant children
- Californians protest middle school for hiring white man to teach cultural studies
- Killer’s sentencing overturned because mother couldn’t find seat in courtroom
- Hillary: ‘Dead broke’ comment was ‘inartful,’ but insists it was ‘accurate’
- Fla. mom arrested for allowing 7-year-old son to walk to park alone
Stock rally evaporates after Bernanke testimony
Question of the Day
On Friday, after the government reported that the country created only 69,000 jobs in May, gold rocketed $58 an ounce, partly because investors believed the Fed might step in.
The sharp moves up and down aren’t likely to stop until there’s a clear answer from the Fed, said Jon Nadler, senior analyst at Kitco Metals. That may take until June 20, when the Fed holds its next policy meeting.
“This is a market built on anticipation and little else,” he said.
Michelle Girard, senior U.S. economist with Royal Bank of Scotland, said the Fed may extend a program called Operation Twist, in which it sells short-term securities and buys long-term bonds to drive down long-term interest rates, for a few months. That program is set to expire at the end of this month.
Investor fear has grown recently that Greece will leave the euro currency union, triggering a financial a panic in Europe and dragging down the rest of the world economy.
Some fear over Europe was allayed Thursday when Spain raised $2.6 billion from the bond market. The interest rate on its benchmark 10-year note fell to 6.02 percent from 6.26 percent late Wednesday in trading on the secondary market, a sign that bond investors have more confidence in Spain’s finances.
Among stocks making big moves in the U.S.:
• Pharmacyclics Inc. rose $1.96, or 6 percent, to $36.73 after an analyst predicted that the company’s experimental lymphoma drug could grow into a blockbuster product.
• Molina Healthcare, an insurance company, plunged $7.99, or 31 percent, to $17.77 after it withdrew its 2012 profit forecast, citing a possible revenue shortfall in Texas.
• Men’s Wearhouse dropped $6.72, or 19 percent, to $28.85 after reporting disappointing financial results and issuing a weak forecast for its second quarter.
TWT Video Picks
- Boehner rules out impeachment: 'Scam started by Democrats'
- Federal judge grants 90-day stay in D.C. gun case
- GOP Senate candidate: Obama needs to visit Central America
- Obama thanks Muslims for 'building the very fabric of our nation'
- Smugglers, rainstorm combine to poke holes in border fence
- California's Jerry Brown cites God, 'religious call' to embrace illegals
- D.C. seeks to stay judge's order allowing gun owners to carry in public
- Kerry's credibility questioned as fighting in Gaza rages
- Hillary Clinton: Forget Obama, George W. Bush made her 'proud to be an American'
- Appeals court upholds Obamacare tax as constitutional
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world